STOCK TITAN

Walker & Dunlop CFO granted 85.221 dividend rights

Walker & Dunlop’s CFO received additional dividend equivalent rights tied to existing restricted stock units, increasing his directly held derivative equivalents.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Walker & Dunlop, Inc. (symbol: WD) is the issuer of record for a Form 4 filing submitted to the SEC. Florkowski Gregory reported acquisition or exercise transactions in this Form 4 filing.

Walker & Dunlop, Inc. reported that its EVP & Chief Financial Officer, Gregory Florkowski, received a grant of 85.221 dividend equivalent rights on September 3, 2026. Each right is the economic equivalent of one share of common stock and relates to previously granted restricted stock units.

Following this award, Florkowski holds a total of 333.226 dividend equivalent rights directly. These rights accrue on his restricted stock units and vest proportionately with the underlying units. No Rule 10b5-1 trading plan is reported for this transaction.

Positive

  • None.

Negative

  • None.
Insider Florkowski Gregory
Role EVP & Chief Financial Officer
Type Security Shares Price Value
Grant/Award Dividend Equivalent Rights F1, F2 85.221 $0.00 $0.00
Holdings After Transaction: Dividend Equivalent Rights — 333.226 contracts (Direct)
Footnotes (2)
  1. F1. Each dividend equivalent right is the economic equivalent of one share of common stock of the Company.
  2. F2. The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate.
Dividend equivalent rights granted 85.221 rights Grant to EVP & Chief Financial Officer on September 3, 2026
Dividend equivalent rights after transaction 333.226 rights Total directly held by the reporting person after the grant
Reported price per dividend equivalent right $0.0000 per right Grant of 85.221 dividend equivalent rights on September 3, 2026
Underlying common stock equivalent 85.221 shares Each new dividend equivalent right is the economic equivalent of one share of common stock
Dividend Equivalent Rights financial
"Each dividend equivalent right is the economic equivalent of one share"
Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.
restricted stock units financial
"rights accrued on restricted stock units held by the reporting person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
economic equivalent financial
"each dividend equivalent right is the economic equivalent of one share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did WD disclose for CFO Gregory Florkowski?

WD disclosed that CFO Gregory Florkowski received a grant of 85.221 dividend equivalent rights on September 3, 2026, which are tied to his existing restricted stock units and are economically equivalent to common shares.

How many dividend equivalent rights does the WD CFO hold after this transaction?

After the September 3, 2026 award, the WD CFO directly holds 333.226 dividend equivalent rights, each economically equivalent to one share of Walker & Dunlop common stock and vesting with the related restricted stock units.

What are dividend equivalent rights in the context of WD’s Form 4?

For WD, each dividend equivalent right is disclosed as the economic equivalent of one share of common stock. These rights accrue on restricted stock units held by the reporting person and vest proportionately with those units.

Were the WD CFO’s dividend equivalent rights granted under a Rule 10b5-1 plan?

No. The filing indicates no Rule 10b5-1 trading plan for this transaction, meaning the grant of 85.221 dividend equivalent rights was not reported as made under a pre-arranged trading plan.

Do the WD dividend equivalent rights have an exercise or conversion price?

The reported grant of 85.221 dividend equivalent rights shows a price of $0.0000 per right and no separate conversion or exercise price, reflecting that they track and vest with the underlying restricted stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Florkowski Gregory

(Last)(First)(Middle)
C/O WALKER & DUNLOP, INC.
7272 WISCONSIN AVENUE, SUITE 1300

(Street)
BETHESDA MARYLAND 20814

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Walker & Dunlop, Inc. [ WD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Dividend Equivalent Rights(1)09/03/2026A85.221 (2) (2)Common Stock85.221$0333.226D
Explanation of Responses:
1. Each dividend equivalent right is the economic equivalent of one share of common stock of the Company.
2. The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate.
/s/ Nicholas C. Eckstein, Attorney-in-fact09/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading